Table 3

Adjusted ORs using osmolaritymax as the design variable in patients with or without respiratory admission diagnosis

Model1Model2
VariableOR95% CIpVariableOR95% CIp
osmolaritymax (<290)2.221.37 to 3.60<0.001osmolaritymax (<290)1.640.68 to 3.940.26
osmolaritymax (290–309)Ref.osmolaritymax (290–309)Ref.
osmolaritymax (310–319)1.981.69 to 2.33<0.001osmolaritymax (310–319)1.260.89 to 1.780.18
osmolaritymax (320–329)3.202.69 to 3.82<0.001osmolaritymax (320–329)1.170.79 to 1.740.4
osmolaritymax (330–339)3.933.20 to 4.82<0.001osmolaritymax (330–339)1.510.92 to 2.460.10
osmolaritymax (≥340)4.453.58 to 5.53<0.001osmolaritymax (≥340)2.031.20 to 3.420.01
Vasopressin use1.891.54 to 2.31<0.001Vasopressin use2.051.17 to 3.570.01
Fluid electrolyte disorder1.421.25 to 1.61<0.001Congestive heart failure1.401.06 to 1.860.02
Lymphoma disease2.031.36 to 3.040.001Lymphoma disease3.431.57 to 7.490.01
Metastatic cancer3.162.48 to 4.01<0.001Metastatic cancer3.382.34 to 4.89<0.001
Maximum SOFA score1.231.21 to 1.25<0.001Maximum SOFA score1.271.22 to 1.32<0.001
Gender1.581.40 to 1.78<0.001
Cardiac arrhythmia1.521.33 to 1.74<0.001
Paralysis1.521.02 to 2.290.04
  • Notes: Model1 contains information from 14 736 patients with non–respiratory admission diagnosis and the mean VIF was 1.43. Model2 contains information from 1750 patients with respiratory admission diagnosis and the mean VIF was 1.40. osmolaritymax represents the maximum serum osmolarity during intensive care unit stay and was categorised into six levels.

  • SOFA, sequential organ failure assessment; VIF, variance inflation factor.